My watch list
my.bionity.com  
Login  

355 Current news from israel

rss
matching the following criteria

Danaher controls more than 98% of Nobel Biocare and started squeeze out procedure

Nobel Biocare applied for delisting

21-Jan-2015

Nobel Biocare Holding AG has been informed that Danaher Corporation filed a petition with the Commercial Court of the Canton of Zurich for the annulation (Kraftloserklärung) of the remaining publicly held registered shares of Nobel Biocare against payment of the offer price that had been offered ...

more

Nobel Biocare appoints new Chief Financial Officer

08-Jan-2015

Nobel Biocare announced that effective February 1, 2015, Mr. Tullio Di Dio will be appointed Chief Financial Officer of Nobel Biocare succeeding Mr. Oliver Walker as he has decided to leave the company to pursue his career interests outside Nobel Biocare. Mr. Di Dio joins Nobel Biocare with 23 ...

more

New leaders elected for the Royal Swedish Academy of Sciences

23-Dec-2014

At the general meeting, the Royal Swedish Academy of Sciences elected its two foremost representatives, who will take over the roles of the current President and Permanent Secretary on 1 July 2015. Christina Moberg to be the new President The new President, the foremost representative of the ...

more

Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease

23-Dec-2014

Swedish Orphan Biovitrum AB and partner Auxilium Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the use of Xiapex® (collagenase clostridium histolyticum) for the treatment of ...

more

Recipharm acquires Flamel Technologies facility and extend development services in France

01-Dec-2014

Recipharm AB and Flamel Technologies SA announced that they have entered into a long term collaboration and signed an agreement whereby Recipharm will purchase Flamel’s development and manufacturing facility located in Pessac, France. Recipharm will significantly expand its pharmaceutical ...

more

Recipharm acquires Lusomedicamenta for SEK 1 billion

17-Nov-2014

The Pharmaceutical Contract Development and Manufacturing Organisation, Recipharm AB (publ) has acquired Lisbon based CDMO Lusomedicameta Sociedade Técnica Farmacêutica S.A.Lusomedicamenta, together with its subsidiary, had twelve month revenues and adjusted EBITDA for non-recurring items to end ...

more

Glionova Therapeutics secures $5.7 million to take glioblastoma therapy into clinic

14-Nov-2014

Glionova Therapeutics announced that it has closed a SEK 42 million (US$ 5.7 million) Series A financing co-led by Novo Seeds and the company’s founding investor, HealthCap to take its lead compound GLN-1001 for treatment of glioblastoma into clinical trials.“We welcome this significant support ...

more

Mapping the spread of diarrhoea bacteria a major step towards new vaccine

13-Nov-2014

Every year hundreds of thousands of people die from diarrhoeal diseases caused by ETEC bacteria. A study published in Nature Genetics describes how Swedish researchers have mapped the spread of strains of ETEC bacteria around the world. It provides key information about how pathogenic bacteria ...

more

Mechanism that repairs brain after stroke discovered

14-Oct-2014

A previously unknown mechanism through which the brain produces new nerve cells after a stroke has been discovered at Lund University and Karolinska Institute in Sweden. The findings have been publishedin the journal SCIENCE. A stroke is caused by a blood clot blocking a blood vessel in the ...

more

The Nobel Prize in Chemistry 2014: Surpassing the limitations of the light microscope

Eric Betzig, Stefan W. Hell and William E. Moerner are awarded the Nobel Prize in Chemistry

08-Oct-2014

For a long time optical microscopy was held back by a presumed limitation: that it would never obtain a better resolution than half the wavelength of light. Helped by fluorescent molecules the Nobel Laureates in Chemistry 2014 ingeniously circumvented this limitation. Their ground-breaking work ...

more

Page 1 From 36
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE